Results 61 to 70 of about 4,986,084 (399)

Incremental benefit of high dose compared to standard dose influenza vaccine in reducing hospitalizations

open access: yesnpj Vaccines
Evidence regarding the high-dose (HD) vaccine’s relative vaccine effectiveness (rVE) and absolute benefit in reducing influenza-related hospitalizations compared to the standard-dose (SD) vaccine is warranted. We estimated the adjusted rVE and the number
Shlomit Yaron   +7 more
doaj   +1 more source

Medical cannabis for treatment-resistant combat PTSD

open access: yesFrontiers in Psychiatry, 2023
Targeting the endocannabinoid system may have a role in the treatment of post-traumatic stress disorder (PTSD). However, few studies have examined the effectiveness of cannabis on symptoms of PTSD, and more research is needed to ascertain cannabis ...
Nitsa Nacasch   +3 more
doaj   +1 more source

Obesity prevention and the role of hospital and community-based health services: a scoping review

open access: yesBMC Health Services Research, 2019
BackgroundControl of obesity is an important priority to reduce the burden of chronic disease. Clinical guidelines focus on the role of primary healthcare in obesity prevention.
C. Pearce   +3 more
semanticscholar   +1 more source

Internet based health information resources for community information services [PDF]

open access: yes, 2003
Health Information Resources on the net is growing day by day. Today it contains a variety of services and sources. This paper mainly attempts to bring out the Health Information resources on the Internet for effective community information ...
Basimalla, Solomon Raju
core  

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

Evaluating provider- and patient-related drivers of why care is not concordant with guidelines for patients with multiple chronic conditions

open access: yesInternational Journal of Integrated Care, 2019
Introduction: Patient centred care is often at odds with disease-focused evidence-based clinical practice, particularly for patients with multiple chronic conditions (CCs).
Chandra Cohen-Stavi   +4 more
doaj   +1 more source

Mental illness stigma and associated factors among Arabic-speaking refugee and migrant populations in Australia

open access: yesInternational Journal of Mental Health Systems, 2023
Background Arabic-speaking refugee and migrant populations form a significant proportion of Australia’s population. Despite high levels of psychological distress among Arabic-speaking populations, low uptake of mental health services has been ...
Ritesh Chimoriya   +7 more
doaj   +1 more source

Unmet Mental Health Treatment Need and Attitudes Toward Online Mental Health Services Among Community College Students.

open access: yesPsychiatric Services, 2018
OBJECTIVE A survey assessed use of and attitudes toward online mental health services among community college students to inform how such services may contribute to reducing unmet treatment need.
M. Dunbar   +4 more
semanticscholar   +1 more source

Jails and Community-Based Health Care [PDF]

open access: yes, 2008
Outlines RWJF's Community-Oriented Correctional Health Services (COCHS) approach to providing medical care to inmates with chronic illnesses -- connecting them with community health centers to be assigned dually based physicians and case ...

core  

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy